DNAJC5 and malaria: Overall, these data suggest that vaccine-induced polyclonal repeat- and C-CSP-specific antibodies may interact cooperatively with (or at least do not lower the efficacy of) potent repeat mAbs to neutralize SPZ in vivo and that passive administration of protective PfCSP mAbs in RTS,S- or R21-vaccinated individuals will provide enhanced protection against malaria.